Advertisement
Screener

AbbVie Inc. (ABBV) Cash Flow Breakdown

AbbVie Inc. Cash Flow Breakdown

Cash flow breakdown shows where AbbVie Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $19.03B came in.
  • Fiscal year ended 2025-12-31: from investing, $6.64B went out.
  • Fiscal year ended 2025-12-31: from financing, $12.72B went out.
  • Fiscal year ended 2025-12-31: change in cash, $295.00M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2025-12-31$19.03B-$6.64B-$980.00M-$11.66B$3.99B-$2.30B*$172.00M$68.00M-$2.02B*-$295.00M
2024-12-31$18.81B-$20.82B-$1.71B-$11.03B$16.96B-$5.01B*$214.00M$57.00M-$4.70B*-$7.29B
2023-12-31$22.84B-$2.01B-$1.97B-$10.54B$0.00*$180.00M$48.00M-$4.94B*$3.61B
2022-12-31$24.94B-$623.00M-$1.49B-$10.04B$2.00B$0.00$262.00M$30.00M-$15.56B*-$545.00M
2021-12-31$22.78B-$2.34B-$934.00M-$9.26B$1.00B$0.00*$244.00M$24.00M-$10.11B*$1.30B
2020-12-31$17.59B-$37.56B-$978.00M-$7.72B$3.00B$0.00*$209.00M$8.00M-$6.02B*-$31.48B
2019-12-31$13.32B$596.00M-$629.00M-$6.37B$31.48B-$3.70B*$8.00M$35.00M-$2.12B*$32.63B
2018-12-31$13.43B-$1.01B-$12.01B-$5.58B$5.96B$3.30B*$73.00M$14.00M-$6.15B*-$2.01B
2017-12-31$9.96B-$274.00M-$1.41B-$4.11B$0.00$23.00M*$254.00M$21.00M-$293.00M*$4.20B
2016-12-31$7.04B-$6.07B-$6.03B-$3.72B$11.63B-$23.00M*$268.00M$29.00M-$6.08B*-$3.30B
2015-12-31$7.54B-$12.94B-$7.59B-$3.29B$20.66B-$19.00M$155.00M$36.00M-$4.20B*$51.00M
2014-12-31$3.55B-$926.00M-$665.00M-$2.66B$12.00M$232.00M-$53.00M-$158.00M*-$1.25B
2013-12-31$6.27B$879.00M-$320.00M-$2.56B-$601.00M$347.00M-$66.00M-$247.00M*$3.69B
2012-12-31$6.34B-$2.42B$14.59B$1.00B-$151.00M-$13.50B*
2011-12-31$6.25B$553.00M-$21.00M-$6.76B*

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$3.44B*-$1.20B*-$9.00M*-$3.07B*$0.00*$0.00*$25.00M*-$2.00B*
2026-03-31$3.83B-$574.00M-$1.49B-$3.09B$7.99B-$2.50B*$2.00M$4.16B
2025-12-31$5.22B*-$1.46B*-$3.00M*-$2.91B*$0.00*-$1.29B*$48.00M*-$1.00M*-$8.00M*
2025-09-30$7.02B*-$3.26B*-$4.00M*-$2.91B*$0.00*-$2.56B*$63.00M*-$1.00M*$820.00M*
2025-06-30$5.15B*-$1.18B*-$12.00M*-$2.91B*$0.00*-$44.00M*$5.00M*$3.00M*$248.00M*
2025-03-31$1.64B-$735.00M-$961.00M-$2.92B$3.99B$1.59B*$67.00M-$3.03B*-$349.00M
2024-12-31$7.05B*-$1.87B*-$358.00M*-$2.75B*$2.00B*$0.00*$10.00M*$1.00M*-$5.76B*
2024-09-30$5.45B*-$8.26B*-$17.00M*-$2.75B*$0.00*$0.00*$67.00M*$32.00M*-$403.00M*
2024-06-30$2.27B*-$1.10B*-$9.00M*-$2.75B*$0.00*-$3.00M*$10.00M*$0.00*-$3.35B*
2024-03-31$4.04B-$9.59B-$1.32B-$2.77B$14.96B-$5.00B*$127.00M$24.00M$4.81B*$5.25B
2023-12-31$4.75B*-$800.00M*-$3.00M*-$2.63B*$0.00*$31.00M*-$2.00M*-$1.85B*
2023-09-30$7.57B*-$369.00M*-$4.00M*-$2.63B*$0.00*$0.00*$36.00M*$30.00M*-$96.00M*
2023-06-30$6.32B*-$341.00M*-$10.00M*-$2.63B*$0.00*$0.00*$48.00M*-$1.00M*-$1.33B*
2023-03-31$4.19B-$499.00M-$1.96B-$2.66B$0.00$0.00$65.00M$21.00M-$1.66B*-$2.49B
2022-12-31$7.43B*-$448.00M*-$4.00M*-$2.51B*$0.00*$53.00M*-$11.00M*-$7.17B*
2022-09-30$7.60B*$1.29B*-$4.00M*-$2.50B*$0.00*$11.00M*$15.00M*-$3.04B*
2022-06-30$5.00B*$130.00M*-$9.00M*-$2.51B*$0.00*$70.00M*$5.00M*-$238.00M*
2022-03-31$4.91B-$1.59B-$1.47B-$2.53B$2.00B$128.00M$21.00M-$5.13B*-$3.65B
2021-12-31$5.08B*-$1.15B*-$131.00M*-$2.31B*$0.00*$75.00M*$2.00M*-$3.97B*
2021-09-30$7.93B*-$615.00M*-$6.00M*-$2.31B*$1.00B*$25.00M*$21.00M*-$2.37B*
2021-06-30$4.89B*-$242.00M*-$10.00M*-$2.31B*$73.00M*$5.00M*-$3.64B*
2021-03-31$4.88B-$342.00M-$787.00M-$2.32B$71.00M-$4.00M-$132.00M*$1.31B
2020-12-31$4.85B*-$627.00M*-$296.00M*-$2.10B*$0.00*$0.00*$100.00M*-$20.00M*-$1.38B*
2020-09-30$5.83B*-$1.15B*-$20.00M*-$2.10B*$0.00*$0.00*$32.00M*$8.00M*-$734.00M*
2020-06-30$3.09B*-$35.65B*-$19.00M*-$1.75B*$0.00*$65.00M*-$5.00M*-$859.00M*
2020-03-31$3.81B-$129.00M-$643.00M-$1.76B$0.00*$12.00M$25.00M-$53.00M*$1.22B
2019-12-31$3.27B*-$615.00M*-$2.00M*-$1.59B*$29.95B*$0.00*$2.00M*-$1.00M*-$1.75B*$29.28B*
2019-09-30$4.55B*$1.38B*-$4.00M*-$1.59B*-$306.00M*$1.00M*$15.00M*$1.44B*$5.48B*
2019-06-30$2.48B*-$140.00M*-$3.00M*-$1.59B*-$193.00M*$1.00M*$0.00*-$283.00M*$275.00M*
2019-03-31$3.02B-$27.00M-$620.00M-$1.59B-$3.20B*$4.00M$21.00M-$2.39B
2018-12-31$3.39B*-$283.00M*-$2.06B*-$1.45B*$0.00*$699.00M*$7.00M*-$2.00M*-$1.02B*-$726.00M*
2018-09-30$4.52B*-$963.00M*-$1.01B*-$1.46B*-$509.00M*$2.00M*$11.00M*$3.88B*$4.47B*
2018-06-30$2.87B*$687.00M*-$7.52B*-$1.53B*$144.00M*$2.00M*-$32.00M*-$45.00M*-$5.46B*
2018-03-31$2.65B-$447.00M-$1.43B-$1.14B-$33.00M*$62.00M$37.00M-$7.00M*-$296.00M
2017-12-31$2.58B*$201.00M*-$505.00M*-$1.03B*$0.00*-$400.00M*$40.00M*-$26.00M*-$7.00M*$857.00M*
2017-09-30$3.27B*-$109.00M*-$5.00M*-$1.03B*$0.00*$400.00M*$65.00M*$29.00M*-$273.00M*$2.36B*
2017-06-30$2.00B*$318.00M*-$5.00M*-$1.02B*$0.00*$64.00M*-$8.00M*-$7.00M*$1.35B*
2017-03-31$2.10B-$684.00M-$895.00M-$1.03B$23.00M$85.00M$26.00M-$6.00M*-$360.00M
2016-12-31-$1.81B*-$933.00M*$3.86B*$377.00M*$58.00M*-$35.00M*-$4.01B*-$1.12B*
2016-09-30$1.45B*-$199.00M*-$6.00M*-$933.00M*$0.00*-$494.00M*$41.00M*$22.00M*-$1.00M*-$109.00M*
2016-06-30$1.92B*-$4.30B*-$3.81B*-$927.00M*$94.00M*$92.00M*-$1.00M*$5.71B*-$1.23B*
2016-03-31$2.13B-$1.46B-$409.00M-$924.00M-$6.00M$77.00M$43.00M-$843.00M
2015-12-31$1.96B*-$297.00M*-$1.24B*-$840.00M*$4.00B*-$354.00M*$32.00M*-$19.00M*-$4.01B*-$824.00M*
2015-09-30$2.15B*$745.00M*-$998.00M*-$850.00M*$5.00M*$760.00M*$22.00M*$9.00M*-$4.00M*$1.82B*
2015-06-30$1.83B*-$12.51B*-$5.00B*-$818.00M*-$569.00M*$54.00M*-$20.00M*$16.52B*-$506.00M*
2015-03-31$1.58B-$873.00M-$342.00M-$786.00M$144.00M$47.00M$66.00M-$59.00M*-$442.00M
2014-12-31-$578.00M*$2.51B*-$313.00M*-$674.00M*$124.00M*$68.00M*-$11.00M*-$76.00M*$629.00M*
2014-09-30$1.79B*-$2.28B*$1.00M*-$673.00M*$50.00M*$37.00M*$1.00M*-$135.00M*-$1.37B*
2014-06-30$1.72B*-$359.00M*-$24.00M*-$673.00M*$248.00M*$42.00M*-$61.00M*$53.00M*
2014-03-31$624.00M-$797.00M-$329.00M-$641.00M-$410.00M$85.00M$18.00M
2013-12-31$1.25B*$123.00M*-$201.00M*-$641.00M*$2.00M*$103.00M*$10.00M*-$20.00M*
2013-09-30$1.80B*-$964.00M*$2.00M*-$640.00M*$1.00M*$54.00M*$25.00M*-$55.00M*
2013-06-30$2.04B*$233.00M*-$24.00M*-$638.00M*-$3.00M*$99.00M*-$4.00M*$70.00M*
2013-03-31$1.19B$1.49B-$97.00M-$636.00M-$601.00M$91.00M-$97.00M-$242.00M*
2012-12-31$941.00M*-$206.00M*-$139.00M*$2.53B*
2012-09-30$2.25B*-$1.81B*-$4.00M*$2.25B*
2012-06-30$1.56B*-$202.00M*$1.00M*-$1.33B*
2012-03-31$1.59B-$204.00M-$9.00M-$1.37B*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Merck & Co., Inc. (MRK)United States$365.215B99.96
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60